The Mediclinic Board of Directors (the “Board”), as well as all relevant employees, particularlyemployees managing the supply chain across the Group, have been informed about the regulatory requirements to ensure an understanding of the risks, the Group’s position on slavery and human trafficking, to manage those risks accordingly and to further stay abreast of global developments in this regard.1